News | RIVM

First care workers vaccinated with AstraZeneca on Friday

The first AstraZeneca vaccines will be administered in the Netherlands this Friday. This will happen at the GGD vaccination site in The Hague.

Minor decrease across the Netherlands, but not in all regions

In the period from 3 to 9 February, the reported number of people who tested positive for COVID-19 was 24,668. There were fewer reported positive tests, but the number only decreased by 14%, which was a smaller decrease than in recent weeks.

Traffic sign COVID-19 testing and vaccination location

People living in small-scale residential facilities vaccinated sooner by deploying Moderna as well as Pfizer/BioNTech

Starting next week, vaccination for clients receiving care under the Long-Term Care Act, who are living in small-scale residential facilities without an institutional physician, will be expanded to the Pfizer/BioNTech vaccine and Moderna vaccine.

Man receives COVID-19 vaccination at GGD vaccination site

Lareb notes newly reported deaths shortly after vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a total of 15 reports so far regarding deaths shortly after receiving the COVID-19 vaccinations.

New research in GGD test lanes on spread of coronavirus SARS-CoV-2

RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.

80 to 84-year-olds invited for vaccination sooner

Starting tomorrow, the first people in the age group from 80-84 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.

New variants disrupt plans

In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.

One person died shortly after COVID-19 vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.

Nationwide assessment of SARS-CoV-2 laboratories: very high quality

The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.

RIVM will calculate temporary background value for PFAS in soil

In the coming weeks, RIVM will derive a temporary background value for PFAS in Dutch soil. This will be done based on measurement data from the provinces in the Netherlands.